Special items: Ovarian Cancer and Us blog best viewed in Firefox

Friday, June 11, 2010

The drug, Patupilone, failed to show improvements over existing drugs in 829 patients with advanced ovarian cancer.


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.